Viamet Release: FDA Grants Fast Track...

Viamet Release: FDA Grants Fast Track Designation To VT-1598 For Treatment Of Valley Fever

Jul 13, 2017 Read more: BioSpace

Viamet Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration has granted Fast Track designation to VT-1598, a novel oral agent for the treatment of coccidioidomycosis, also known as Valley Fever. Valley Fever is an invasive fungal infection that is highly concentrated in the San Joachin Valley in California .

Start the conversation, or Read more at BioSpace.

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.